Zhiwu Wang

Sep 24, 2024 | onlinelibrary.wiley.com | Zhanlin Ji |Xiaoyu Li |Zhiwu Wang |Haiyang Zhang

1 Introduction Colorectal cancer (CRC) is one of the most common cancer types worldwide and a major contributor to cancer-related deaths. It is estimated that by 2023, approximately 150 000 people are diagnosed with CRC, and about 50 000 of them will succumb to the disease [1]. Fortunately, CRC is curable when detected early. For early-diagnosed patients at stage I of the disease, the 5-year survival rate exceeds 90% [2].